4 U.S. companies will pay $26 billion... By James L. Ferraro | Opioid Epidemic , Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Defective medical devices and drugs recalled By James L. Ferraro | Pharmaceutical Litigation , Products Liability | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration recalls diabetes drug By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
FDA releases guidelines to curb nizatidine drug... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Janssen Pharmaceuticals hid Elmiron drug injuries information By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Drug injuries: Is a pharmaceutical company liable... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More
Mislabeled medications could cause drug injuries By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Purdue Pharma could pay $13 billion in... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Elmiron use linked to loss of vision:... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Purdue Pharma faces $13 billion in penalties... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Have current events made the opioid epidemic... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration issues Class I... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More